AEMETIS ($AMTX) posted quarterly earnings results on Thursday, November 6th. The company reported earnings of -$0.37 per share, missing estimates of -$0.22 by $0.15. The company also reported revenue of $59,190,000, missing estimates of $88,776,108 by $-29,586,108.
You can see Quiver Quantitative's $AMTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
AEMETIS Insider Trading Activity
AEMETIS insiders have traded $AMTX stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $AMTX stock by insiders over the last 6 months:
- FRANCIS P BARTON has made 0 purchases and 4 sales selling 26,452 shares for an estimated $67,016.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
AEMETIS Hedge Fund Activity
We have seen 31 institutional investors add shares of AEMETIS stock to their portfolio, and 53 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 1,818,055 shares (-75.0%) from their portfolio in Q2 2025, for an estimated $4,508,776
- MILLENNIUM MANAGEMENT LLC added 546,928 shares (+inf%) to their portfolio in Q2 2025, for an estimated $1,356,381
- GEODE CAPITAL MANAGEMENT, LLC removed 425,682 shares (-43.0%) from their portfolio in Q2 2025, for an estimated $1,055,691
- STATE STREET CORP removed 417,973 shares (-55.3%) from their portfolio in Q2 2025, for an estimated $1,036,573
- GOLDMAN SACHS GROUP INC added 325,671 shares (+149.1%) to their portfolio in Q2 2025, for an estimated $807,664
- CITADEL ADVISORS LLC added 256,645 shares (+inf%) to their portfolio in Q2 2025, for an estimated $636,479
- JANE STREET GROUP, LLC added 255,675 shares (+inf%) to their portfolio in Q2 2025, for an estimated $634,074
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
AEMETIS Analyst Ratings
Wall Street analysts have issued reports on $AMTX in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Ascendiant Capital issued a "Buy" rating on 10/06/2025
- UBS issued a "Buy" rating on 06/30/2025
To track analyst ratings and price targets for AEMETIS, check out Quiver Quantitative's $AMTX forecast page.
AEMETIS Price Targets
Multiple analysts have issued price targets for $AMTX recently. We have seen 2 analysts offer price targets for $AMTX in the last 6 months, with a median target of $12.0.
Here are some recent targets:
- Edward Woo from Ascendiant Capital set a target price of $21.0 on 10/06/2025
- Manav Gupta from UBS set a target price of $3.0 on 06/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
